| |
|
|
Sam Sung Pharm.Ind.Co.,Ltd. (001360) |
|
|
STOCK |
|
|
|
  |
(unit : Won, Share) |
| Fiscal Year End |
06.12 | 07.12 | 08.12 | 09.09 |
| Par Value |
5,000 | 5,000 | 5,000 | 5,000 |
| Yearly Highest Price |
5,370 | 5,440 | 4,590 | 3,845 |
| Yearly Lowest Price |
3,435 | 3,025 | 2,140 | 2,600 |
| Common Shares O/S |
7,589,733 | 7,589,733 | 7,589,733 | 7,589,733 |
| Preferred Shares O/S |
- | - | - | - |
| Market Cap.(100Mn.Won) |
354 | 269 | 207 | 249 |
| Dividends (%) |
- | - | - | - |
|
 |
(Company/Sector/Market) |
| |
2008.06 | 2009.06 |
| Beta |
0.59 / 0.68 / 1.00 | 0.50 / 0.54 / 1.00 |
| Volatility |
48.51 / 23.43 / 26.01 | 48.97 / 32.47 / 41.28 |
|
 |
(unit : Won) |
| Fiscal Year End |
06.12 | 07.12 | 08.12 | 09.09 |
| Earnings Per Share |
- 2,056 | - 312 | 84 | 154 |
| Sales Per Share |
4,894 | 4,345 | 4,403 | 4,810 |
| Book Value Per Share |
2,892 | 2,585 | 4,475 | 4,593 |
| Cash Flow Per Share |
- 221.48 | - 197.72 | 143.13 | - 202.99 |
|
 |
(Unit : Times) |
| Fiscal Year End |
06.12 | 07.12 | 08.12 | 09.09 |
| Price / Earnings (H/L) |
-/- | -/- | 54.64/25.48 | 24.86/16.81 |
| Price / Sales (H/L) |
1.10/0.70 | 1.25/0.70 | 1.04/0.49 | 0.80/0.54 |
| Price / Book (H/L) |
1.86/1.19 | 2.10/1.17 | 1.03/0.48 | 0.84/0.57 |
| Price / Cash Flow (H/L) |
- /- | - /- | 32.07 / 14.95 | - /- |
|
 |
(Unit : 100Mn.Won, %) |
| Fiscal Year End |
05.12 |
06.12 |
07.12 |
08.12 |
| Company |
Sector |
Company |
Sector |
Company |
Sector |
Company |
Sector |
| Invested Capital |
597 |
731 |
611 |
714 |
621 |
708 |
676 |
942 |
| NOPLAT |
2 |
70 |
- 32 |
54 |
10 |
60 |
24 |
71 |
| Return on Invested Capital |
0 |
9 |
- 5 |
7 |
1 |
8 |
3 |
7 |
| WACC |
7 |
6 |
7 |
6 |
7 |
6 |
7 |
6 |
| Economic Value Added |
- 40.7 |
22.1 |
- 81.0 |
8.6 |
- 33.9 |
10.9 |
- 28.8 |
5.3 |
|
 |
(Unit : 100Mn.Won, Times) |
| Fiscal Year End |
2006.12 | 2007.12 | 2008.12 | 2009.09 |
| Enterprise Value(EV) |
458.44 | 401.44 | 352.58 | 417.04 |
| EBITDA |
- 93.79 | 6.97 | 31.51 | 13.86 |
| EBITDA/Sales |
- 0.33 | 0.02 | 0.09 | 0.04 |
| EBITDA/Financial Exp. |
- 5.72 | 0.43 | 1.71 | 1.13 |
| EV/EBITDA |
- | 57.60 | 11.19 | 30.09 |
|
|
|
|
